Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enlivity is a private medical nutrition company focused on supportive care for people undergoing cancer treatment. The company markets Healios, a nutrient-based oral solution designed to help prevent or manage oral mucositis, also known as cancer mouth sores, associated with chemotherapy and radiation therapy. Enlivity positions its products as science-backed, easy-to-use, and accessible supportive care tools intended to improve patient quality of life and help patients stay on treatment. The business appears to be commercial-stage rather than a traditional drug-development biotech, with its lead offering sold directly through its website and promoted to both patients and healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enlivity.